Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection
Phase 3
Withdrawn
- Conditions
- Covid19Pneumonia, Viral
- Interventions
- Drug: Antiviral Agents
- First Posted Date
- 2020-12-19
- Last Posted Date
- 2020-12-21
- Lead Sponsor
- Blessing Corporate Services, Inc
- Registration Number
- NCT04675086
- Locations
- 🇺🇸
Blessing Corporate Services, Inc, Hannibal, Missouri, United States
News
No news found